SCHEMBL8709606

SCHEMBL8709606

O[C]CC1CCCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3596245 0.78
SCHEMBL31384945 0.78
SCHEMBL4202751 0.78
SCHEMBL4195520 0.78
Hydrochloric Acid SCHEMBL29753774 0.77 HRH3 (0.38)
Hydrochloric Acid SCHEMBL29753797 0.77 HRH3 (0.38)
Hydrochloric Acid SCHEMBL29753801 0.77 HRH3 (0.38)
Hydrochloric Acid SCHEMBL19510774 0.77 HRH3 (0.38)
SCHEMBL3303200 0.75
SCHEMBL213201 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0646119-B1 QUATERNARY NITROGEN-CONTAINING PHOSPHONATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM AS WELL AS DENTAL CALCULUS AND PLAQUE PROCTER & GAMBLE PHARMA (US) 1998-07-15 EP disclosed
EP-0849272-A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque Procter & Gamble Pharmaceuticals, Inc. (US) 1998-06-24 EP disclosed
US-5770586-A Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque THE PROCTER & GAMBLE COMPANY (US) 1998-06-23 US disclosed
US-5391743-A Treating osteoporosis, rheumatoid arthritis, osteoarthritis PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1995-02-21 US disclosed